537253 SUNLOC

Sunil Healthcare Share Price

 

 

Start SIP in SUNLOC

Start SIP

Performance

  • Low
  • ₹66
  • High
  • ₹69
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹95
  • Open Price₹68
  • Previous Close₹69
  • Volume701

Investment Returns

  • Over 1 Month -8.43%
  • Over 3 Month -14.9%
  • Over 6 Month -13.9%
  • Over 1 Year -6.5%

Smart Investing Starts Here Start SIP with Sunil Healthcare for Steady Growth!

Invest Now

Sunil Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.9
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 71
  • P/B Ratio
  • Average True Range
  • 2.73
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.2
  • RSI
  • 40.96
  • MFI
  • 59.32

Sunil Healthcare Financials

Sunil Healthcare Technicals

EMA & SMA

Current Price
₹68.95
-0.05 (-0.07%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹70.79
  • 50 Day
  • ₹73.15
  • 100 Day
  • ₹75.09
  • 200 Day
  • ₹76.27

Resistance and Support

67.96 Pivot Speed
  • R3 72.90
  • R2 70.92
  • R1 69.94
  • S1 66.98
  • S2 65.00
  • S3 64.02

Sunil Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-04 Quarterly Results
2025-07-30 Quarterly Results
2025-05-29 Audited Results
2025-02-13 Quarterly Results
2024-11-13 Quarterly Results

Sunil Healthcare F&O

Sunil Healthcare Shareholding Pattern

73.53%
0.1%
17.85%
8.52%

Sunil Healthcare FAQs

Sunil Healthcare share price is ₹68 As on 10 December, 2025 | 17:31

The Market Cap of Sunil Healthcare is ₹70.7 Cr As on 10 December, 2025 | 17:31

The P/E ratio of Sunil Healthcare is 40.9 As on 10 December, 2025 | 17:31

The PB ratio of Sunil Healthcare is 1 As on 10 December, 2025 | 17:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23